SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-343736
Filing Date
2018-12-06
Accepted
2018-12-06 16:20:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d659084dsc13d.htm SC 13D 52913
  Complete submission text file 0001193125-18-343736.txt   54366
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90199 | Film No.: 181220925
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 955 MASSACHUSETTS AVE CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVE CAMBRIDGE MA 02139 339-203-1076
X4 Pharmaceuticals, Inc. (Filed by) CIK: 0001632304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D